Manuel B. Graeber

University of Sydney, Australia

Manuel B. Graeber, M.D., Ph.D., F.R.C.Path., serves as a German-British Neuropathologist and the Barnet-Cropper Chair of Brain Tumor Research at the Brain and Mind Research Institute (BMRI) of the University of Sydney. Following his first position as a Staff Member at the Max-Planck Institute for Psychiatry in Munich, Germany (1987-1989), he spent three years as a Postdoctoral Fellow at the Harvard Medical School in Boston, Mass, USA. From 1992 to 1999, he returned to Munich, where he headed a molecular neuropathology laboratory at the University of Munich and at the Max-Planck Institute of Neurobiology, respectively. While in Munich, he rediscovered the histological material of Alois Alzheimer's original cases. In 2000, he founded the University Department of Neuropathology at Imperial College and Hammersmith Hospitals Trust, London, UK, which he led as a Chairman until he decided to close it down for ethical reasons related to brain banking in its eighth year. Later, in 2007 he cochaired the launch of the European Fellowship in Neuropathology. Following a sabbatical to write up research on Parkinson's disease, he headed the Division of Neuropathology at the King Fahad Medical City, Ministry of Health, Riyadh, KSA, for one year. He became affiliated with the BMRI in 2009 and moved to Sydney in 2010. His awards include the Otto-Hahn Medal of the Max-Planck Society, the Gerhard Hess Award of the German Research Foundation and a Center of Excellence Visiting Scientist Award from the National Institute of Neuroscience, Tokyo, Japan. He is a Cofounding Editor of Neurogenetics and a Member of several editorial boards. The role of microglia in synaptic plasticity is one of his main research interests.